Form 8-K - Current report:
SEC Accession No. 0001837607-25-000030
Filing Date
2025-04-21
Accepted
2025-04-21 16:11:36
Documents
18
Period of Report
2025-04-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aeon-20250419x8k.htm   iXBRL 8-K 54861
2 EX-10 aeon-20250419xex10.htm EX-10 680164
3 GRAPHIC aeon-20250419xex10001.jpg GRAPHIC 863
4 GRAPHIC aeon-20250419xex10007.jpg GRAPHIC 863
5 GRAPHIC aeon-20250419xex10009.jpg GRAPHIC 723
  Complete submission text file 0001837607-25-000030.txt   943686

Data Files

Seq Description Document Type Size
6 EX-101.SCH aeon-20250419.xsd EX-101.SCH 4044
7 EX-101.DEF aeon-20250419_def.xml EX-101.DEF 2869
8 EX-101.LAB aeon-20250419_lab.xml EX-101.LAB 17853
9 EX-101.PRE aeon-20250419_pre.xml EX-101.PRE 10675
20 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20250419x8k_htm.xml XML 5048
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 25853256
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)